Episode 22: Cells, microbes and cell therapy

This episode will present: the development of an innovative therapeutic platform for CDKL5 Deficiency Disorder as a non invasive, accessible oral treatment using engineered bacteria as a therapeutic vehicle; photobiomodulation as a potential new non invasive therapy for skeletal muscle tissue regeneration; a 3D model differentiated from perinatal stem cells as a potential therapy for type 1 diabetes; and a multidimensional approach to post transplant outcome assessment based on outcome indicators and interdisciplinary interventions.